NC lawsuit shield falters in legislature

Anyone who's been anticipating a lawsuit shield in North Carolina will have to wait. As Pharmalot reports, the state's legislature has pulled a proposal that would have protected drugmakers from liability lawsuits over FDA-approved drugs. The provision was yanked from a pending bill and sent to a study committee, meaning that the soonest it might be revived is 2012.

The idea of federal preemption--that FDA approval should shield drugs from state-court lawsuits--has been bandied about quite a lot in recent years. Court cases that might have set a precedent for preemption didn't end up working out that way, but advocates of the idea have proposed state legislation addressing the idea.

Michigan, for instance, now has a comprehensive law that limits consumers' ability to recover damages from drugmakers, provided the offending product was FDA-approved. North Carolina's proposal at first would have surpassed Michigan's in its corporate protections, but it was softened as it moved its way through the legislature.

- read the Pharmalot report

Suggested Articles

Bristol-Myers already has one Opdivo combo approved in kidney cancer, but it’s going for another—and new trial data could be just the ticket.

Trodelvy's bladder cancer data look weaker compared with what Seattle Genetics' rival drug Padcev achieved in its own trial.

Merck’s Keytruda is battling Bristol Myers' Opdivo in adjuvant melanoma, and it just racked up trial results that will help it even the playing field.